Azmaril®
Azmaril®
Bronchodilator...Anti-Couph

Indication

Azmaril® syrup:

  • is an expectorant and bronchodilaltor. 
  • Prescribed for bronchial asthma patients.
  • Prescribed for chronic bronchitis , and emphysema.

Composition

Each 10 ml of Azmaril® syrup contain:

  • Terbutaline sulphate       2.5mg.
  • Bromhexine hydrochloride   8 mg.
  • Menthol                    5mg.
  • Guaifenesin                100mg.

Dosage

Azmaril® oral syrup used:
¤ For adults:

  • One tablespoonful (10ml) three times daily.

¤ For children :

  • 2 - 5 years : half teaspoonful (2.5ml) three times daily.
  • 6 - 12 years :1 teaspoonful (5ml) three times daily.

Azmaril® Syrup contains four active substances:

  • Terbutaline sulphate, a bronchodilator used in case of reversible bronchospasm (asthma) and in chronic obstructive bronchial disease.
  • Bromhexine hydrochloride, a mucolytic which liquefies the viscous bronchial mucus.
  • Guaifenesin, which is used as an expectorant to increase the volume of sputum and decrease its thickness that help patient to remove the sputum , also help to convert the dry cough to wet cough that lead to decrease the suffering of patients.
  • Menthol which relieves the symptoms of upper respiratory & sinuses infection.

Each 10 ml of Azmaril® syrup contain:

  • Terbutaline sulphate       2.5mg.
  • Bromhexine hydrochloride   8 mg.
  • Menthol                    5mg.
  • Guaifenesin                100mg.

Azmaril® syrup:

  • is an expectorant and bronchodilaltor. 
  • Prescribed for bronchial asthma patients.
  • Prescribed for chronic bronchitis , and emphysema.

Azmaril® is contraindicated:

  • in patients with known hypersensitivity to any of its components,
  • in the first three months of pregnancy,
  • in patient suffering from high blood pressure or acute heart diseases.
  • Azmaril® as it contains bromhexine, may enhance the activity of the antibiotics (tetracycline and erythromycin).
  • Azmaril® is not recommended to be used concomitantly with other bronchodilator such as epinephrine and with antidepressant agents such as (tricyclic).

¤ Azmaril® rarely causes:

  • (dizziness, nausea, vomiting, headache, sweating, tachycardia),

these reactions are transient in nature or disappear upon reducing the dosage. All these reactions are similar to those commonly seen with other sympathomimetic agents.

Azmaril® oral syrup used:
¤ For adults:

  • One tablespoonful (10ml) three times daily.

¤ For children :

  • 2 - 5 years : half teaspoonful (2.5ml) three times daily.
  • 6 - 12 years :1 teaspoonful (5ml) three times daily.
  • Azmaril® should be used with caution in case of sever bronchial asthma and under medical supervision.
  • Should be used with caution in patient with diabetes mellitus, hypertension, hyperthyroidism, coronary insufficiency and in case of renal and hepatic failure.
  • Used under medical supervision in patient with sever cardiovascular disorders.
  • Should be used with care in case of pregnancy and lactation.
  • Bottle of 100 ml oral solution.
  • Store at a temperature not exceeding 25ºC.